ADAM19 is tightly associated with constitutive Alzheimer's disease APP α-secretase in A172 cells

Biochemical and Biophysical Research Communications

Volumn 352, Issue 1, 2007, Pages 111-117

  Tanabe, Chiaki ^a   Hotoda, Nika ^a   Sasagawa, Noboru ^a   Sehara Fujisawa, Atsuko ^b   Maruyama, Kei ^c   Ishiura, Shoichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Secretase; ADAM19; Alzheimer's disease; APP

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN; PROTEIN ADAM19;

ALZHEIMER DISEASE; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RNA INTERFERENCE;

ADAM PROTEINS; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; CELL LINE; DNA, COMPLEMENTARY; HUMANS; MEMBRANE PROTEINS; PROTEIN BINDING; RNA INTERFERENCE; TRANSFECTION;

EID: 33751409639     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.181     Document Type: Article

References (18)

1. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
2. Koike H., Tomioka S., Sorimachi H., Saido T.C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K., and Ishiura S. Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343 (1999) 371-375
3. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., and Fahrenholz F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 96 (1999) 3922-3927
4. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., and Black R.A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273 (1998) 27765-27767
5. Hotoda N., Koike H., Sasagawa N., and Ishiura S. A secreted form of human ADAM9 has an alpha-secretase activity for APP. Biochem. Biophys. Res. Commun. 293 (2002) 800-805
6. Weskamp G., Cai H., Brodie T.A., Higashyama S., Manova K., Ludwig T., and Blobel C.P. Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol. Cell. Biol. 22 (2002) 1537-1544
7. Hartmann D., de Strooper B., Serneels L., Craessaerts K., Herreman A., Annaert W., Umans L., Lubke T., Lena Illert A., von Figura K., and Saftig P. The disintegrin/metalloprotease ADAM10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 11 (2002) 2615-2624
8. Postina R., Schroeder A., Dewachter I., Bohl J., Schmitt U., Kojro E., Prinzen C., Endres K., Hiemke C., Blessing M., Flamez P., Dequenne A., Godaux E., van Leuven F., and Fahrenholz F. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113 (2004) 1456-1464
9. Slack B.E., Ma L.K., and Seah C.C. Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-α converting enzyme. Biochem. J. 357 (2001) 787-794
10. Asai M., Hattori C., Szabo B., Sasagawa N., Maruyama K., Tanuma S., and Ishiura S. Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretase. Biochem. Biophys. Res. Commun. 301 (2003) 231-235
11. Skovronsky D.M., Moore D.B., Milla M.E., Doms R.W., and Lee V.M. Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J. Biol. Chem. 275 (2000) 2568-2575
12. Kawaguchi N., Xu X., Tajima R., Kronqvist P., Sundberg C., Loechel F., Albrechtsen R., and Wewer U.M. ADAM12 protease induces adipogenesis in transgenic mice. Am. J. Pathol. 160 (2002) 1895-1903
13. Shirakabe K., Wakatsuki S., Kurisaki T., and Fujisawa-Sehara A. Roles of Meltrin beta/ADAM19 in the processing of neuregulin. J. Biol. Chem. 276 (2001) 9352-9358
14. Chesneau V., Becherer J.D., Zheng Y., Erdjument-Bromage H., Tempst P., and Blobel C.P. Catalytic properties of ADAM19. J. Biol. Chem. 278 (2003) 22331-22340
15. Wong B.R., Rho J., Arron J., Robinson E., Orlinick J., Chao M., Kalachikov S., Cayani E., Bartlett III F.S., Frankel W.N., Lee S.Y., and Choi Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272 (1997) 25190-25194
16. Zimmermann M., Gardoni F., Marcello E., Colciaghi F., Borroni B., Padovani A., Cattabeni F., and Di Luca M. Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. J. Neurochem. 90 (2004) 1489-1499
17. Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160 (2003) 113-123
18. Wakatsuki S., Kurisaki T., and Sehara-Fujisawa A. Lipid rafts identified as locations of ectodomain shedding mediated by Meltrin beta/ADAM19. J. Neurochem. 89 (2004) 119-123